Silver Book Fact

The prevalence of valve disease increases with age, from 0.7% in participants 18-44 to 13.3% in participants 75 years of age or older.

Nkomo, Vuyisile, Julius Gardin, Thomas Skelton, John Gottdiener, Christopher Scott, Maurice Enriquez-Sarano. Burden of Valvular Heart Diseases: a population-based study. Lancet. September 2006; 368(9540): 1005-11. http://www.ncbi.nlm.nih.gov/pubmed/16980116

Reference

Title
Burden of Valvular Heart Diseases: a population-based study
Publication
Lancet
Publication Date
September 2006
Authors
Nkomo, Vuyisile, Julius Gardin, Thomas Skelton, John Gottdiener, Christopher Scott, Maurice Enriquez-Sarano
Volume & Issue
Volume 368, Issue 9540
Pages
1005-11
URL
Read Full Resource

Categories

  • Cost of Disease
  • Age - A Major Risk Factor

Related Facts

  • By 2030, it is projected that an additional 3 million people will have heart failure–a 25% increase in prevalence from 2010.  
  • Venous thromboembolism in hospital mortality rate
    About 1 in 8 patients who develop venous thromboembolism in the hospital will die as a result.  
  • In 2009, there were 12,826,000 physician office visits, 639,000 emergency department visits, and 589,000 outpatient department visits with a primary diagnosis of coronary heart disease.  
  • AFib prevalence projected to double by 2050
    By 2050, the prevalence of atrial fibrillation will have more than doubled since 2001—growing to an estimated 5.6 million to 12.1 million Americans.  
  • Prevalence of AS in Americans 75+
    An estimated 12.4%, or ~2.5 million people ages 75+ in North America, have AS.